Utility of combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors

Oral Oncology

Volumn 45, Issue 3, 2009, Pages 218-224

  Roh, Jong Lyel ^a   Kim, Jae Seung ^a   Lee, Jeong Hyun ^a   Cho, Kyung Ja ^a   Choi, Seung Ho ^a   Nam, Soon Yuhl ^a   Kim, Sang Yoon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cancer of unknown primary; Cervical metastasis; Computed tomography; Distant metastasis; FDG PET CT; Oral cavity

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER SURGERY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; LYMPH NODE METASTASIS; MALE; MOUTH CANCER; NASOPHARYNX CANCER; NECK DISSECTION; PALATINE TONSIL; PAROTID GLAND CANCER; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; SALIVARY GLAND CANCER; SALIVARY GLAND CARCINOMA; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; THYROID CANCER; TONSIL CANCER; TUMOR BIOPSY; UNDIFFERENTIATED CARCINOMA; CANCER STAGING; COHORT ANALYSIS; DIAGNOSTIC USE; EVALUATION STUDY; HEAD AND NECK NEOPLASMS; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SECONDARY; WHOLE BODY IMAGING;

ADULT; AGED; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 60249093424     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.05.010     Document Type: Article

References (25)

1. Adams S., Baum R.P., Stuckensen T., Bitter K., and Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25 9 (1998) 1255-1260
2. Stokkel M.D., ten Broek F.W., Hordijk G.J., Koole R., and van Rijk P.P. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg 231 2 (2000) 229-234
3. 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 28 7 (2001) 816-821
4. 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol 18 10 (2007) 1698-1703
5. 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope 115 11 (2005) 2029-2034
6. 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. Semin Nucl Med 35 4 (2005) 214-219
7. Kostakoglu L., Leonard J.P., Kuji I., Coleman M., Vallabhajosula S., and Goldsmith S.J. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 94 4 (2002) 879-888
8. Regelink G., Brouwer J., de Bree R., Pruim J., van der Laan B.F., Vaalburg W., et al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging 29 8 (2002) 1024-1030
9. 18F-fluoro-2-deoxy-d-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 112 11 (2002) 2009-2014
10. Rusthoven K.E., Koshy M., and Paulino A.C. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 101 11 (2004) 2641-2649
11. 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 30 4 (2008) 471-478
12. Beyer T., Townsend D.W., Brun T., Kinahan P.E., Charron M., Roddy R., et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 41 8 (2000) 1369-1379
13. Branstetter IV B.F., Blodgett T.M., Zimmer L.A., Snyderman C.H., Johnson J.T., Raman S., et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone?. Radiology 235 2 (2005) 580-586
14. Schoder H., Yeung H.W., Gonen M., Kraus D., and Larson S.M. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 231 1 (2004) 65-72
15. Antoch G., Saoudi N., Kuehl H., Dahmen G., Mueller S.P., Beyer T., et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22 21 (2004) 4357-4368
16. Paul S.A., Stoeckli S.J., von Schulthess G.K., and Goerres G.W. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary. Eur Arch Oto-Rhino-Laryngol 264 2 (2007) 189-195
17. Wartski M., Le Stanc E., Gontier E., Vilain D., Banal A., Tainturier C., et al. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun 28 5 (2007) 365-371
18. Som P.M., Curtin H.D., and Mancuso A.A. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol 174 3 (2000) 837-844
19. Miller F.R., Karnad A.B., Eng T., Hussey D.H., Stan McGuff H., and Otto R.A. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 30 1 (2008) 28-34
20. AAssar O.S., Fischbein N.J., Caputo G.R., Kaplan M.J., Price D.C., Singer M.I., et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology 210 1 (1999) 177-181
21. Jungehülsing M., Scheidhauer K., Damm M., Pietrzyk U., Eckel H., Schicha H., et al. 2[F]-fluoro-2-deoxy-d-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 123 3 (2000) 294-301
22. Houghton D.J., Hughes M.L., Garvey C., Beasley N.J., Hamilton J.W., Gerlinger I., et al. Role of chest CT scanning in the management of patients presenting with head and neck cancer. Head Neck 20 7 (1998) 614-618
23. de Bree R., Deurloo E.E., Snow G.B., and Leemans C.R. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 110 3 Pt 1 (2000) 397-401
24. Brouwer J., Senft A., de Bree R., Comans E.F., Golding R.P., Castelijns J.A., et al. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?. Oral Oncol 42 3 (2006) 275-280
25. Schmid D.T., Stoeckli S.J., Bandhauer F., Huguenin P., Schmid S., von Schulthess G.K., et al. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 113 5 (2003) 888-891